CVE-2018-1086

Description

pcs before versions 0.9.164 and 0.10 is vulnerable to a debug parameter removal bypass. REST interface of the pcsd service did not properly remove the pcs debug argument from the /run_pcs query, possibly disclosing sensitive information. A remote attacker with a valid token could use this flaw to elevate their privilege.

Categories

4.3
CVSS
Severity: Medium
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.40%
Vendor Advisory redhat.com Vendor Advisory redhat.com Vendor Advisory debian.org
Affected: redhat pcs
Published at:
Updated at:

References

Link Tags
https://bugzilla.redhat.com/show_bug.cgi?id=CVE-2018-1086 issue tracking third party advisory
https://access.redhat.com/errata/RHSA-2018:1060 third party advisory vendor advisory
https://access.redhat.com/errata/RHSA-2018:1927 third party advisory vendor advisory
https://www.debian.org/security/2018/dsa-4169 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2018-1086?
CVE-2018-1086 has been scored as a medium severity vulnerability.
How to fix CVE-2018-1086?
To fix CVE-2018-1086, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2018-1086 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2018-1086 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2018-1086?
CVE-2018-1086 affects redhat pcs.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.